refavip.blogg.se

The results of this study could be useful in the development of universal health insurance in Korea.Our Social Vision

For diabetes, the ICERs were US$2,960 per additional life-year gained and US$1,368 per additional QALY gained. For mental disorders, the ICERs were US$12,547 per additional life-year gained and US$9,471 per additional QALY gained. For chronic lower respiratory diseases, the ICERs were US$47,669 per additional life-year gained and US$14,966 per additional QALY gained. For cancers, the ICER for a universal policy was US$12,645 per additional life-year gained and US$3,909 per additional QALY gained. That is, universal health insurance is most cost-effective for managing these diseases. The model’s results indicated that for the target diseases, universal health insurance was most likely cost-effective when costing US$90 per month. Incremental cost-effectiveness ratios (ICERs) were calculated as the incremental costs of universal health insurance per one additional life-year gained, one additional quality-adjusted life year (QALY) gained, and one additional person treated. In this study, the cost of universal health insurance was assumed to be US$90 per month. Utility values were estimated from the literature. Target diseases were cancers, chronic lower respiratory diseases, mental disorders, and diabetes. A decision analytic model was developed for a hypothetical cohort of Korean female adults aged 20 to 64 years.

The purpose of this study is to introduce the concept of health insurance cost-effectiveness and apply it to universal health insurance in Korea. fr Rank: (Rank based on keywords, cost and organic traffic) n/a OrganicIntroducing cost-effectiveness analysis of universal health insurance in Korea.